[1]Beall,HowardD.;Winski,Shannon;Swann,Elizabeth;Hudnott,AnnaR.;Cotterill,AnnS.;O'Sullivan,Noeleen;Green,StephenJ.;Bien,Richard;Siegel,David;Ross,David;Moody,ChristopherJ.[JournalofMedicinalChemistry,1998,vol.41,#24,p.4755-4766]
[1]Everett,StevenA.;Naylor,MatthewA.;Barraja,Paola;Swann,Elizabeth;Patel,KantilalB.;Stratford,MichaelR.L.;Hudnott,AnnaR.;Vojnovic,Borivoj;Locke,RosalindJ.;Wardman,Peter;Moody,ChristopherJ.[Perkin2,2001,#5,p.843-860]
192820-78-3
100-02-7
161518-24-7
[1]Swann;Moody;Stratford;Patel;Naylor;Vojnovic;Wardman;Everett[Perkin2,2001,#8,p.1340-1345]
[1]Beall,HowardD.;Winski,Shannon;Swann,Elizabeth;Hudnott,AnnaR.;Cotterill,AnnS.;O'Sullivan,Noeleen;Green,StephenJ.;Bien,Richard;Siegel,David;Ross,David;Moody,ChristopherJ.[JournalofMedicinalChemistry,1998,vol.41,#24,p.4755-4766]
Title: Role for NAD(P)H:quinone oxidoreductase 1 and manganese-dependent superoxide dismutase in 17-(allylamino)-17-demethoxygeldanamycin-induced heat shock protein 90 inhibition in pancreatic cancer cells.
Journal: The Journal of pharmacology and experimental therapeutics 20110301
Title: ES936 stimulates DNA synthesis in HeLa cells independently on NAD(P)H:quinone oxidoreductase 1 inhibition, through a mechanism involving p38 MAPK.
Journal: Chemico-biological interactions 20100730
Title: NAD(P)H:quinone oxidoreductase 1-compromised human bone marrow endothelial cells exhibit decreased adhesion molecule expression and CD34+ hematopoietic cell adhesion.
Journal: The Journal of pharmacology and experimental therapeutics 20100701
Title: Synthesis and evaluation of 3-aryloxymethyl-1,2-dimethylindole-4,7-diones as mechanism-based inhibitors of NAD(P)H:quinone oxidoreductase 1 (NQO1) activity.
Journal: Journal of medicinal chemistry 20071115
Title: Development of indolequinone mechanism-based inhibitors of NAD(P)H:quinone oxidoreductase 1 (NQO1): NQO1 inhibition and growth inhibitory activity in human pancreatic MIA PaCa-2 cancer cells.
Journal: Biochemistry 20070522
Title: Role of NAD(P)H:quinone oxidoreductase 1 in clofibrate-mediated hepatoprotection from acetaminophen.
Journal: Toxicology 20070212
Title: The highly expressed and inducible endogenous NAD(P)H:quinone oxidoreductase 1 in cardiovascular cells acts as a potential superoxide scavenger.
Journal: Cardiovascular toxicology 20070101
Title: The bioreduction of a series of benzoquinone ansamycins by NAD(P)H:quinone oxidoreductase 1 to more potent heat shock protein 90 inhibitors, the hydroquinone ansamycins.
Journal: Molecular pharmacology 20061001
Title: 5-Methoxy-1,2-dimethyl-3-[(4-nitrophenoxy)methyl]indole-4,7-dione, a mechanism-based inhibitor of NAD(P)H:quinone oxidoreductase 1, exhibits activity against human pancreatic cancer in vitro and in vivo.
Journal: Molecular cancer therapeutics 20060701
Title: The crystal structure of NAD(P)H quinone oxidoreductase 1 in complex with its potent inhibitor dicoumarol.
Journal: Biochemistry 20060523
Title: Formation of 17-allylamino-demethoxygeldanamycin (17-AAG) hydroquinone by NAD(P)H:quinone oxidoreductase 1: role of 17-AAG hydroquinone in heat shock protein 90 inhibition.
Journal: Cancer research 20051101
Title: Dicoumarol relieves serum withdrawal-induced G0/1 blockade in HL-60 cells through a superoxide-dependent mechanism.
Journal: Biochemical pharmacology 20050601
Title: RH1 induces cellular damage in an NAD(P)H:quinone oxidoreductase 1-dependent manner: relationship between DNA cross-linking, cell cycle perturbations, and apoptosis.
Journal: The Journal of pharmacology and experimental therapeutics 20050501
Title: NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger.
Journal: Molecular pharmacology 20040501
Title: Biochemical, cytotoxic, and genotoxic effects of ES936, a mechanism-based inhibitor of NAD(P)H:quinone oxidoreductase 1, in cellular systems.
Journal: Molecular pharmacology 20030901
Title: Kinetics of NAD(P)H:quinone oxidoreductase I (NQO1) inhibition by mitomycin C in vitro and in vivo.
Journal: The Journal of pharmacology and experimental therapeutics 20030601
Title: Characterization of a mechanism-based inhibitor of NAD(P)H:quinone oxidoreductase 1 by biochemical, X-ray crystallographic, and mass spectrometric approaches.
Journal: Biochemistry 20011218
